Annovis Bio, Inc. Accounts Payable
Annovis Bio, Inc. (ANVS) had Accounts Payable of $3.33 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $3.33M.
- 2026-03-31: Accounts Payable, Current $5.28M.
- 2025-12-31: Accounts Payable, Current $2.59M.
- 2025-09-30: Accounts Payable, Current $2.11M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $3.33M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $5.28M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $2.59M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $2.11M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $974.31K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.37M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.31M 10-K · filed 2026-03-13 |
| 2024-09-30 | $4.10M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $3.39M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $4.11M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.29M 10-K · filed 2025-03-21 |
| 2023-09-30 | $1.93M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.17M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $4.15M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $3.96M 10-K · filed 2024-03-29 |
| 2022-09-30 | $1.85M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $901.84K 10-Q · filed 2023-08-14 |
| 2022-03-31 | $929.00K 10-Q · filed 2023-05-10 |
| 2021-12-31 | $688.07K 10-K · filed 2023-03-31 |
| 2021-09-30 | $289.74K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $114.83K 10-Q · filed 2021-07-28 |
| 2021-03-31 | $824.57K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $341.86K 10-K · filed 2022-03-02 |
| 2020-09-30 | $139.78K 10-Q · filed 2020-11-04 |
| 2020-06-30 | $124.44K 10-Q · filed 2020-07-29 |
| 2020-03-31 | $54.53K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $1.23M 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |